116 related articles for article (PubMed ID: 38216092)
1. Identification of MCM4 and PRKDC as new regulators of osteosarcoma cell dormancy based on 3D cell cultures.
Jubelin C; Muñoz-Garcia J; Ollivier E; Cochonneau D; Vallette F; Heymann MF; Oliver L; Heymann D
Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119660. PubMed ID: 38216092
[TBL] [Abstract][Full Text] [Related]
2. Expression and Clinical Significance of High-Mobility Group AT-hook 2 (HMGA2) in Osteosarcoma.
Cui J; Dean D; Hornicek FJ; Yi G; Duan Z
Orthop Surg; 2022 May; 14(5):955-966. PubMed ID: 35388973
[TBL] [Abstract][Full Text] [Related]
3. Technical report: liquid overlay technique allows the generation of homogeneous osteosarcoma, glioblastoma, lung and prostate adenocarcinoma spheroids that can be used for drug cytotoxicity measurements.
Jubelin C; Muñoz-Garcia J; Cochonneau D; Ollivier E; Vallette F; Heymann MF; Oliver L; Heymann D
Front Bioeng Biotechnol; 2023; 11():1260049. PubMed ID: 37869710
[No Abstract] [Full Text] [Related]
4. Expression and significance of Annexin A3 in the osteosarcoma cell lines HOS and U2OS.
Zeng X; Wang S; Gui P; Wu H; Li Z
Mol Med Rep; 2019 Sep; 20(3):2583-2590. PubMed ID: 31524248
[TBL] [Abstract][Full Text] [Related]
5. DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas.
Hu T; He N; Yang Y; Yin C; Sang N; Yang Q
J Exp Clin Cancer Res; 2015 Feb; 34(1):22. PubMed ID: 25884381
[TBL] [Abstract][Full Text] [Related]
6. Establishment of new multidrug-resistant human osteosarcoma cell lines.
Oda Y; Matsumoto Y; Harimaya K; Iwamoto Y; Tsuneyoshi M
Oncol Rep; 2000; 7(4):859-66. PubMed ID: 10854558
[TBL] [Abstract][Full Text] [Related]
7. Deletion of
Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Kubota Y; Bouvet M; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2022; 19(3):299-304. PubMed ID: 35430564
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells.
Kimura R; Ishikawa C; Rokkaku T; Janknecht R; Mori N
Biochim Biophys Acta; 2011 Aug; 1813(8):1543-53. PubMed ID: 21640141
[TBL] [Abstract][Full Text] [Related]
9. In vivo gene transfer between interacting human osteosarcoma cell lines is associated with acquisition of enhanced metastatic potential.
Tome Y; Tsuchiya H; Hayashi K; Yamauchi K; Sugimoto N; Kanaya F; Tomita K; Hoffman RM
J Cell Biochem; 2009 Oct; 108(2):362-7. PubMed ID: 19623575
[TBL] [Abstract][Full Text] [Related]
10. UBE2L3 Promotes Oxidative Stress-regulated Necroptosis to Accelerate Osteosarcoma Progression.
Zhao X; Shan G; Xing D; Gao H; Xiong Z; Hui W; Gong M
Recent Pat Anticancer Drug Discov; 2024 Feb; ():. PubMed ID: 38385491
[TBL] [Abstract][Full Text] [Related]
11. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
12. Anti-osteoblastogenic, pro-inflammatory and pro-angiogenic effect of extracellular vesicles isolated from the human osteosarcoma cell line MNNG/HOS.
Ucci A; Cappariello A; Ponzetti M; Tennant F; Loftus AEP; Shefferd K; Maurizi A; Delle Monache S; Teti A; Rucci N
Bone; 2021 Dec; 153():116130. PubMed ID: 34329816
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
Vaidya H; Rumph C; Katula KS
PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
[TBL] [Abstract][Full Text] [Related]
14. Augmented drug resistance of osteosarcoma cells within decalcified bone matrix scaffold: The role of glutamine metabolism.
Ren J; Zhao C; Sun R; Sun J; Lu L; Wu J; Li S; Cui L
Int J Cancer; 2024 May; 154(9):1626-1638. PubMed ID: 38196144
[TBL] [Abstract][Full Text] [Related]
15. Antidifferentiation Noncoding RNA Regulates the Proliferation of Osteosarcoma Cells.
Min L; Hong S; Duan H; Zhou Y; Zhang W; Luo Y; Shi R; Tu C
Cancer Biother Radiopharm; 2016 Mar; 31(2):52-7. PubMed ID: 26986815
[TBL] [Abstract][Full Text] [Related]
16. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis.
Luu HH; Kang Q; Park JK; Si W; Luo Q; Jiang W; Yin H; Montag AG; Simon MA; Peabody TD; Haydon RC; Rinker-Schaeffer CW; He TC
Clin Exp Metastasis; 2005; 22(4):319-29. PubMed ID: 16170668
[TBL] [Abstract][Full Text] [Related]
17. Effect and Mechanism of
Li X; Liu LF; Liu YZ; Pan YT; Li G; Lu QY; Li ZC
Balkan Med J; 2018 Mar; 35(2):155-162. PubMed ID: 29363485
[TBL] [Abstract][Full Text] [Related]
18. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
[TBL] [Abstract][Full Text] [Related]
19. Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?
Kendal JK; Singla A; Affan A; Hildebrand K; Al-Ani A; Ungrin M; Mahoney DJ; Itani D; Jirik FR; Monument MJ
Clin Orthop Relat Res; 2020 Dec; 478(12):2921-2933. PubMed ID: 33275394
[TBL] [Abstract][Full Text] [Related]
20. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
